Federal regulators looking into pain management options at the Centers for Disease Control and Prevention have received hundreds of comments related to medical marijuana and more than 1,000 about kratom.
The federal agency’s National Center for Injury Prevention and Control is looking for input on “individual stakeholder’s values and preferences related to pain and pain management options,” it said in an e-mail last week.
“Through this opportunity, CDC is seeking stakeholders’ perspectives on and experiences with pain and pain management, including, but not limited to, the benefits and harms of opioid use,” it said. “CDC invites input specifically on topics focused on using or prescribing opioid pain medications, non-opioid medications, or non-pharmacological treatments (e.g., exercise therapy or cognitive behavioral therapy).”